Clinical Trial Update: VGAIT for Chemotherapy-induced Peripheral Neuropathy [NA]

View source ↗

Summary

Clinical trial update for VGAIT targeting chemotherapy-induced peripheral neuropathy. The study is currently recruiting at Massachusetts General Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• VGAIT

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Chemotherapy-induced Peripheral Neuropathy | NA | Status: RECRUITING